Navigation

ExploreAnalysisInvestor RelationsAI AssistantCompareScreener
LoginSign Up FreeSign Up

© 2026 MarketCI. All rights reserved.

HelpPricingPrivacyTerms
AM

AMGN

Market Closed

Amgen Inc.

NASDAQHealthcareDrug Manufacturers - General
US
31.50K employees
CEO: Robert A. Bradway
Founded: 1983
$460.28
+$0.00(+NaN%)
Market Cap
248.84B
Beta
0.42
52W Range
N/A
Dividend Yield
2.16%
OverviewForecastsFundamentalMarket SentimentValuationOwnership
OverviewForecastsFundamentalMarket SentimentValuationOwnership
Comprehensive Valuation
In-depth valuation analysis including DCF scenarios and peer comparisons.
AI Insight: Amgen's current price sits 24.8% below the high-confidence fair value of $574.36, indicating potential undervaluation. Strong profitability and growth contrast with low leverage, but high Monte Carlo volatility (184.89% CV) signals significant risk. Diverse valuation methods yield wide price ranges, reflecting uncertainty and opportunity.
Enhanced Football Field Analysis
Loading comprehensive valuation data...

Fetching multi-methodology valuation ranges...

Explore AMGN

Overview

Key metrics and AI-powered insights

Forecast

Price targets and earnings estimates

Fundamentals

Income, balance sheet and cash flow

Valuation

P/E, DCF and valuation multiples

Ownership

Institutional and insider holdings

Sentiment

Analyst ratings and news sentiment

AMGN in the Healthcare

Mega Cap
Healthcare

Browse sector stocks →

Drug Manufacturers - General

Browse industry stocks →